257 related articles for article (PubMed ID: 32128294)
1. The Value of Intravenous Immunoglobulin Therapy in Idiopathic Inflammatory Myositis in the Current Transformed Era of Biologics.
Patwardhan A
Cureus; 2020 Feb; 12(2):e7049. PubMed ID: 32128294
[TBL] [Abstract][Full Text] [Related]
2. Biologics in refractory idiopathic inflammatory myositis (IIM): What experience in juvenile vs adult myositis tells us about the use of biologics in pediatric IIM.
Patwardhan A; Spencer CH
Mod Rheumatol; 2021 Sep; 31(5):933-948. PubMed ID: 33499694
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.
Gandiga PC; Ghetie D; Anderson E; Aggrawal R
Curr Rheumatol Rep; 2023 Aug; 25(8):152-168. PubMed ID: 37261663
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis.
Mandel DE; Malemud CJ; Askari AD
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524083
[TBL] [Abstract][Full Text] [Related]
5. Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.
Moghadam-Kia S; Oddis CV; Aggarwal R
Clin Rev Allergy Immunol; 2017 Feb; 52(1):81-87. PubMed ID: 26767526
[TBL] [Abstract][Full Text] [Related]
6. What is New in Idiopathic Inflammatory Myopathies: Mechanisms and Therapies.
Khadilkar SV; Dhamne MC
Ann Indian Acad Neurol; 2020; 23(4):458-467. PubMed ID: 33223661
[TBL] [Abstract][Full Text] [Related]
7. Discovery of new biomarkers of idiopathic inflammatory myopathy.
Lu X; Peng Q; Wang G
Clin Chim Acta; 2015 Apr; 444():117-25. PubMed ID: 25681646
[TBL] [Abstract][Full Text] [Related]
8. Use of intravenous immunoglobulin therapy for myositis: an audit in South Australian patients.
Foreman C; Russo P; Davies N; Hissaria P; Proudman S; Hughes T; Limaye V
Intern Med J; 2017 Jan; 47(1):112-115. PubMed ID: 28076913
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic inflammatory myositis.
Tieu J; Lundberg IE; Limaye V
Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):149-68. PubMed ID: 27421222
[TBL] [Abstract][Full Text] [Related]
10. Current diagnosis and treatment of polymyositis and dermatomyositis.
Sasaki H; Kohsaka H
Mod Rheumatol; 2018 Nov; 28(6):913-921. PubMed ID: 29669460
[TBL] [Abstract][Full Text] [Related]
11. Polymyositis and dermatomyositis - challenges in diagnosis and management.
Yang SH; Chang C; Lian ZX
J Transl Autoimmun; 2019 Dec; 2():100018. PubMed ID: 32743506
[TBL] [Abstract][Full Text] [Related]
12. Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon.
Patwardhan A; Spencer CH
Pediatr Rheumatol Online J; 2019 Aug; 17(1):56. PubMed ID: 31429786
[TBL] [Abstract][Full Text] [Related]
13. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
Love LA; Leff RL; Fraser DD; Targoff IN; Dalakas M; Plotz PH; Miller FW
Medicine (Baltimore); 1991 Nov; 70(6):360-74. PubMed ID: 1659647
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
Ernste FC; Reed AM
Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
[TBL] [Abstract][Full Text] [Related]
15. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
16. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.
Shamim EA; Rider LG; Pandey JP; O'Hanlon TP; Jara LJ; Samayoa EA; Burgos-Vargas R; Vazquez-Mellado J; Alcocer-Varela J; Salazar-Paramo M; Kutzbach AG; Malley JD; Targoff IN; Garcia-De la Torre I; Miller FW
Arthritis Rheum; 2002 Jul; 46(7):1885-93. PubMed ID: 12124873
[TBL] [Abstract][Full Text] [Related]
17. Classification of idiopathic inflammatory myopathies: pathology perspectives.
Tanboon J; Nishino I
Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
[TBL] [Abstract][Full Text] [Related]
18. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy.
Rider LG; Gurley RC; Pandey JP; Garcia de la Torre I; Kalovidouris AE; O'Hanlon TP; Love LA; Hennekam RC; Baumbach LL; Neville HE; Garcia CA; Klingman J; Gibbs M; Weisman MH; Targoff IN; Miller FW
Arthritis Rheum; 1998 Apr; 41(4):710-9. PubMed ID: 9550481
[TBL] [Abstract][Full Text] [Related]
19. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
20. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]